Easton Pharmaceuticals (Easton Pharmaceuticals) Change In Payables And Accrued Expense : $0.02 Mil (TTM As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Change In Payables And Accrued Expense?

Easton Pharmaceuticals's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2021 was $0.01 Mil. It means Easton Pharmaceuticals's Accounts Payable & Accrued Expense increased by $0.01 Mil from Jun. 2021 to Sep. 2021 .

Easton Pharmaceuticals's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2020 was $0.26 Mil. It means Easton Pharmaceuticals's Accounts Payable & Accrued Expense increased by $0.26 Mil from Dec. 2019 to Dec. 2020 .

Easton Pharmaceuticals Change In Payables And Accrued Expense Historical Data

The historical data trend for Easton Pharmaceuticals's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Change In Payables And Accrued Expense Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.37

-0.10

0.38

0.26

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	0.01	0.01	0.01

Easton Pharmaceuticals Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

Easton Pharmaceuticals Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.